About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight People

First Derivatives Founder Brian Conlon Dies

Subscribe to our newsletter

Brian Conlon, the Northern Irish founder and CEO of the £1 billion+ FinTech firm First Derivatives, lost his battle with cancer on July 28, 2019 at the age of 53. Conlon started at KPMG and worked briefly at Morgan Stanley and software firm Sunguard before starting First Derivatives. He listed the company in 2002 but remained its major shareholder. The firm began its search for a new CEO in May, when Conlon was first diagnosed. The search is ongoing.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: How to leverage a market data inventory platform for enterprise-wide gains

What do global heads of market data thinking about the best ways of managing costs? What are the considerations, strengths and weaknesses of a market data inventory platform? Listen to this webinar where we reveal the findings from our survey including: How to best manage market data costs The functions and capabilities to look for...

BLOG

Fenergo Adds Senior Product Leads to Sharpen AI driven CLM and Financial Crime Roadmap

Fenergo has appointed three experienced product leaders – Sharon Bodkin (VP, Banking Product), Neil D’Rosario (VP, Buyside Product) and Adam McLaughlin (Director, Financial Crime Product) – to advance its client?lifecycle management (CLM) and financial?crime portfolio. The roles are effective immediately and align with the company’s push to let financial institutions manage CLM and financial?crime tasks...

EVENT

RegTech Summit London

Now in its 9th year, the RegTech Summit in London will bring together the RegTech ecosystem to explore how the European capital markets financial industry can leverage technology to drive innovation, cut costs and support regulatory change.

GUIDE

What the Global Legal Entity Identifier (LEI) Will Mean for Your Firm

It’s hard to believe that as early as the 2009 Group of 20 summit in Pittsburgh the industry had recognised the need for greater transparency as part of a wider package of reforms aimed at mitigating the systemic risk posed by the OTC derivatives market. That realisation ultimately led to the Dodd Frank Act, and...